Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection
- PMID: 2293502
- PMCID: PMC2589357
Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection
Abstract
Over the last decade, it has become evident that homologous transfusions carry immunologic consequences beyond the well-understood ones of alloimmunization to blood cell antigens. Transfusions constitute temporary transplants of large amounts of allogeneic antigen given intravenously and cause down-regulation of many cellular immune functions. These changes may explain in part the association of transfusion with such clinically important events as (1) improved survival of renal allografts, (2) decreased recurrence rates for autoimmune disease, (3) increased frequency and earlier recurrences of solid tumors, (4) increased frequency of post-operative bacterial infection, and (5) increased severity of viral infection. Preliminary data suggest that, in animal models and clinical settings, syngeneic or autologous transfusions are not associated with such events. This finding supports the hypothesis that these associations are cause and effect and involve immunologic mechanisms.
Similar articles
-
Association of transfusion with postoperative bacterial infection.Crit Rev Clin Lab Sci. 1990;28(2):95-107. doi: 10.3109/10408369009105899. Crit Rev Clin Lab Sci. 1990. PMID: 2073350 Review.
-
Effects of transfusion on immune function. Cancer recurrence and infection.Arch Pathol Lab Med. 1994 Apr;118(4):371-9. Arch Pathol Lab Med. 1994. PMID: 8166587 Review.
-
Transfusion and recipient immune function.Arch Pathol Lab Med. 1989 Mar;113(3):246-53. Arch Pathol Lab Med. 1989. PMID: 2645852 Review.
-
Effect of perioperative blood transfusion on prostate cancer recurrence.Urol Oncol. 2008 Jul-Aug;26(4):364-7. doi: 10.1016/j.urolonc.2007.06.004. Epub 2007 Nov 7. Urol Oncol. 2008. PMID: 18367097
-
Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies.Br J Surg. 1998 Feb;85(2):171-8. doi: 10.1046/j.1365-2168.1998.00698.x. Br J Surg. 1998. PMID: 9501809
Cited by
-
Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.Gastric Cancer. 2016 Jan;19(1):255-63. doi: 10.1007/s10120-014-0456-x. Epub 2015 Jan 7. Gastric Cancer. 2016. PMID: 25563579
-
Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.Br J Cancer. 1998 Jun;77(11):1996-2002. doi: 10.1038/bjc.1998.331. Br J Cancer. 1998. PMID: 9667681 Free PMC article. Clinical Trial.
-
An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products.Eur Arch Otorhinolaryngol. 2011 Dec;268(12):1789-94. doi: 10.1007/s00405-011-1525-y. Epub 2011 Feb 24. Eur Arch Otorhinolaryngol. 2011. PMID: 21347776
-
Perioperative management of hepatic resection.J Gastrointest Oncol. 2012 Mar;3(1):19-27. doi: 10.3978/j.issn.2078-6891.2012.005. J Gastrointest Oncol. 2012. PMID: 22811866 Free PMC article. No abstract available.
-
Prognostic Impact of Splenectomy in Patients with Esophagogastric Junction Carcinoma.In Vivo. 2018 Jan-Feb;32(1):145-149. doi: 10.21873/invivo.11217. In Vivo. 2018. PMID: 29275312 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical